These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 12372592)

  • 41. High density lipoprotein structure-function and role in reverse cholesterol transport.
    Lund-Katz S; Phillips MC
    Subcell Biochem; 2010; 51():183-227. PubMed ID: 20213545
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Trimerized apolipoprotein A-I (TripA) forms lipoproteins, activates lecithin: cholesterol acyltransferase, elicits lipid efflux, and is transported through aortic endothelial cells.
    Ohnsorg PM; Mary JL; Rohrer L; Pech M; Fingerle J; von Eckardstein A
    Biochim Biophys Acta; 2011 Dec; 1811(12):1115-23. PubMed ID: 21930241
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Double belt structure of discoidal high density lipoproteins: molecular basis for size heterogeneity.
    Li L; Chen J; Mishra VK; Kurtz JA; Cao D; Klon AE; Harvey SC; Anantharamaiah GM; Segrest JP
    J Mol Biol; 2004 Nov; 343(5):1293-311. PubMed ID: 15491614
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of an amyloid fibril forming peptide comprising residues 46-59 of apolipoprotein A-I.
    Wong YQ; Binger KJ; Howlett GJ; Griffin MD
    FEBS Lett; 2012 Jun; 586(13):1754-8. PubMed ID: 22609356
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Combined N- and C-terminal truncation of human apolipoprotein A-I yields a folded, functional central domain.
    Beckstead JA; Block BL; Bielicki JK; Kay CM; Oda MN; Ryan RO
    Biochemistry; 2005 Mar; 44(11):4591-9. PubMed ID: 15766290
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of the core lipid on the energetics of binding of ApoA-I to model lipoprotein particles of different sizes.
    Tanaka M; Saito H; Dhanasekaran P; Wehrli S; Handa T; Lund-Katz S; Phillips MC
    Biochemistry; 2005 Aug; 44(31):10689-95. PubMed ID: 16060677
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Methionine oxidized apolipoprotein A-I at the crossroads of HDL biogenesis and amyloid formation.
    Witkowski A; Chan GKL; Boatz JC; Li NJ; Inoue AP; Wong JC; van der Wel PCA; Cavigiolio G
    FASEB J; 2018 Jun; 32(6):3149-3165. PubMed ID: 29401604
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization of human apolipoprotein A-I expressed in Escherichia coli.
    Bergeron J; Frank PG; Emmanuel F; Latta M; Zhao Y; Sparks DL; Rassart E; Denèfle P; Marcel YL
    Biochim Biophys Acta; 1997 Jan; 1344(2):139-52. PubMed ID: 9030191
    [TBL] [Abstract][Full Text] [Related]  

  • 49. First eight residues of apolipoprotein A-I mediate the C-terminus control of helical bundle unfolding and its lipidation.
    Brubaker G; Lorkowski SW; Gulshan K; Hazen SL; Gogonea V; Smith JD
    PLoS One; 2020; 15(1):e0221915. PubMed ID: 31945064
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Apolipoprotein structure and dynamics.
    Gursky O
    Curr Opin Lipidol; 2005 Jun; 16(3):287-94. PubMed ID: 15891389
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A three-dimensional homology model of lipid-free apolipoprotein A-IV using cross-linking and mass spectrometry.
    Tubb MR; Silva RA; Fang J; Tso P; Davidson WS
    J Biol Chem; 2008 Jun; 283(25):17314-23. PubMed ID: 18430727
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The structure of human apolipoprotein C-1 in four different crystal forms.
    McPherson A; Larson SB
    J Lipid Res; 2019 Feb; 60(2):400-411. PubMed ID: 30559175
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dynamics of lipid displacement inside the hydrophobic cavity of a nonspecific lipid transfer protein from
    Madni ZK; Kumar A; Kumar U; Jaiswal D; Salunke DM
    J Biomol Struct Dyn; 2023; 41(12):5839-5849. PubMed ID: 35838149
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The physiology of foamy phagocytes in multiple sclerosis.
    Grajchen E; Hendriks JJA; Bogie JFJ
    Acta Neuropathol Commun; 2018 Nov; 6(1):124. PubMed ID: 30454040
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relapsing-remitting multiple sclerosis patients display an altered lipoprotein profile with dysfunctional HDL.
    Jorissen W; Wouters E; Bogie JF; Vanmierlo T; Noben JP; Sviridov D; Hellings N; Somers V; Valcke R; Vanwijmeersch B; Stinissen P; Mulder MT; Remaley AT; Hendriks JJ
    Sci Rep; 2017 Feb; 7():43410. PubMed ID: 28230201
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prediction of antimicrobial peptides based on sequence alignment and feature selection methods.
    Wang P; Hu L; Liu G; Jiang N; Chen X; Xu J; Zheng W; Li L; Tan M; Chen Z; Song H; Cai YD; Chou KC
    PLoS One; 2011 Apr; 6(4):e18476. PubMed ID: 21533231
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Apolipoprotein A-I mimetic peptide helix number and helix linker influence potentially anti-atherogenic properties.
    Wool GD; Reardon CA; Getz GS
    J Lipid Res; 2008 Jun; 49(6):1268-83. PubMed ID: 18323574
    [TBL] [Abstract][Full Text] [Related]  

  • 58. APD: the Antimicrobial Peptide Database.
    Wang Z; Wang G
    Nucleic Acids Res; 2004 Jan; 32(Database issue):D590-2. PubMed ID: 14681488
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Solution structure of the N-terminal amphitropic domain of Escherichia coli glucose-specific enzyme IIA in membrane-mimetic micelles.
    Wang G; Keifer PA; Peterkofsky A
    Protein Sci; 2003 May; 12(5):1087-96. PubMed ID: 12717030
    [TBL] [Abstract][Full Text] [Related]  

  • 60. How the lipid-free structure of the N-terminal truncated human apoA-I converts to the lipid-bound form: new insights from NMR and X-ray structural comparison.
    Wang G
    FEBS Lett; 2002 Oct; 529(2-3):157-61. PubMed ID: 12372592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.